Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 3, 2015, Pages 633-644

  Fytianos, Kleanthis ^a   Rodriguez Lorenzo, Laura ^a   Clift, Martin J D ^a   Blank, Fabian ^c   Vanhecke, Dimitri ^a   von Garnier, Christophe ^c   Petri Fink, Alke ^a,b   Rothen Rutishauser, Barbara ^a,c  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cell viability; Cellular uptake; Dendritic cells; Gold nanoparticles; Immunological properties

Indexed keywords

CELL DEATH; CHEMICAL ACTIVATION; FIBER OPTIC SENSORS; GOLD COATINGS; GOLD METALLOGRAPHY; GOLD NANOPARTICLES; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; INDUCTIVELY COUPLED PLASMA; LIGHT TRANSMISSION; METAL NANOPARTICLES; OPTICAL EMISSION SPECTROSCOPY;

CELL VIABILITY; CELLULAR UPTAKE; DENDRITIC CELLS; IMMUNOLOGICAL PROPERTIES; INDUCTIVELY COUPLED PLASMA-OPTICAL EMISSION SPECTROMETRY; NEGATIVE SURFACE CHARGES; POLY (VINYL ALCOHOL) (PVA); TUMOR NECROSIS FACTOR ALPHA;

CELL ENGINEERING;

ANTIGEN; GOLD NANOPARTICLE; INTERLEUKIN 1BETA; POLYVINYL ALCOHOL; TUMOR NECROSIS FACTOR ALPHA; BIOMATERIAL; GOLD; IL1B PROTEIN, HUMAN; MACROGOL DERIVATIVE; METAL NANOPARTICLE; POLYETHYLENE GLYCOL 1000;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CELL DEATH; CELL VIABILITY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PROTEIN SECRETION; SURFACE CHARGE; TRANSMISSION ELECTRON MICROSCOPY; CELL CULTURE; CHEMISTRY; CYTOLOGY; IMMUNOLOGY; MONOCYTE; SECRETION (PROCESS);

CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; DENDRITIC CELLS; GOLD; HUMANS; INTERLEUKIN-1BETA; METAL NANOPARTICLES; MONOCYTES; POLYETHYLENE GLYCOLS; POLYVINYL ALCOHOL;

EID: 84930711017     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.11.004     Document Type: Article

References (50)

1. Blank F., Gerber P., Rothen-Rutishauser B., Sakulkhu U., Salaklang J., de Peyer K., et al. Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology 2011, 1(16).
2. Blank F., Stumbles P.A., Seydoux E., Holt P.G., Fink A., Rothen-Rutishauser B., et al. Size-dependent uptake of particles by pulmonary APC populations and trafficking to regional lymph nodes. Am J Respir Cell Mol Biol 2013, 49(1):67-77.
3. Hirosuea S., Kourtis I.C., van der Vlies A.J., Hubbell J.A., Swartz M.A. Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: cross-presentation and T cell activation. Vaccine 2010, 28:7897-7906.
4. Hubbell J.A., Thomas S.N., Swartz M.A. Materials engineering for immunomodulation. Nature 2009, 462(26).
5. Swartz M., Hirosue S., Hubbell J.A. Engineering approaches to immunotherapy. Sci Transl Med 2012, 4(148).
6. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
7. Card J.W., Zeldin D.C., Bonner J.C., Nestmann E.R. Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol 2008, 295.
8. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev 2008, 60.
9. Murphy C., Gole A.M., Stone J.W., Sisco P.N., Alkilany A.M., Goldsmith E.C., et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 2008, 41(12):1721-1730.
10. Kimling J., Maier M., Okenve B., Kotaidis V., Ballot H., Plech A. Turkevich method for gold nanoparticle synthesis revisited. J Phys Chem B 2006, 110:15700-15707.
11. Fadeel B. Clear and present danger? Engineered nanoparticles and the immune system. Swiss Medial Wkly 2012, 142(w13609):1-9.
12. Thakor A.S., Jokerst J., Zavaleta C., Massoud T.F., Gambhir S.S. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett 2011, 4029-4036.
13. Müller L., Gasser M., Raemy D.O., Herzog F., Brandenberger C., Schmid O., et al. Realistic exposure methods for investigating the interaction of nanoparticles with the lung at the air-liquid interface in vitro. InSci J 2011, 1(1):30-64.
14. Gehr P., Bachofen M., Weibel E.R. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol 1978, 32:121-140.
15. von Garnier C., Nicod L.P. Immunology taught by lung dendritic cells. Swiss Medial Wkly 2009, 139(13-14):186-192.
16. Holt P.G., Strickland D.H., Wikström M.E., Jahnsen F.L. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 2008, 8.
17. Demedts I.K., Brusselle G.G., Vermaelen K.Y., Pauwels R.A. Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol 2005, 32:177-184.
18. Mellman I., Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106:255-258.
19. Vermaelen K., Pauwels R. Pulmonary dendritic cells. Am J Respir Crit Care Med 2005, 172.
20. Randall T.D. Pulmonary dendritic cells: thinking globally, acting locally. J Exp Med 2010, 207(3).
21. Holt P.G., Stumbles P.A. Characterization of dendritic cell populations in the respiratory tract. J Aerosol Med 2000, 13:361-367.
22. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10654-20644.
23. Villiers C.L., Freitas H., Couderc R., Villiers M.B., Marche P.N. Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions. J Nanopart Res 2010, 12:55-60.
24. Thomas S.N., van der Vlies A.J., O'Neil C.P., Reddy S.T., Yu S.S., Giorgio D.T., et al. Engineering complement activation on polypropylene sulfide vaccine nanoparticles. Biomaterials 2011, 32:2194-2203.
25. Sung J.C., Pulliam B.L., Edwards D.A. Nanoparticles for drug delivery to the lungs. Trends Biotechnol 2007, 25(12):563-570.
26. Turkevich J., Stevenson P.C., Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951, 11:55-75.
27. Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat Phys Sci 1973, 241:20-22.
28. EFSA Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to the use of polyvinyl alcohol as a coating agent for food supplements (Question number EFSA-Q-2005-017), in The EFSA Journal 2005, 1-15.
29. Alconel S.N.S., Baas A.S., Maynard H.D. FDA-approved poly(ethylene glycol)-protein conjugate drugs. Polym Chem 2011, 2(1442).
30. Hirsch V., Kinnear C., Moniatte M., Rothen-Rutishauser B., Clift M.J.D., Fink A. Surface charge of polymer coated SPIONs influences the serum protein adsorption, colloidal stability and subsequent cell interaction in vitro 7. Nanoscale 2013, 5(9):3723-3732.
31. Mock J.J., Smith D.R., Schultz S. Local refractive index dependence of plasmon resonance spectra from individual nanoparticles. Nano Lett 2003, 3:485-491.
32. Aili D., Gryko P., Sepulveda B., Dich J.A.G., K.N., Heenan R., et al. Polypeptide Folding-mediated tuning of the optical and structural properties of gold nanoparticle assemblies. Nano Lett 2011, 11:5564-5573.
33. Dobrynin A.V., Rubinsteirn M. Theory of polyelectrolytes in solutions and at surfaces. Prog Polym Sci 2005, 30:1049-1118.
34. Brandenberger C., Muhlfeld C., Ali Z., Lenz A.G., Schmid O., Parak W.J., et al. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small 2 2010, 6(15):1669-1678.
35. Karakoti A.S., Soumen D.S., Thevuthasan S., Seal S. PEGylated inorganic nanoparticles. Angew Chem Int Ed 2011, 50:1980-1994.
36. Manson J., Kumar D., Meenan B.J., Dixon D. Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media. Gold Bull 2011, 44(2):99-105.
37. Wang F.K., Phonthammachai N., Mya K.Y., Tjiu W.W., He C.B. PEG-POSS assisted facile preparation of amphiphilic gold nanoparticles and interface formation of Janus nanoparticles. Chem Commun 2011, 47(2):767-769.
38. Sigroni F., Solario R., Lips P.A.M. Segmented multifunctional poly(ether ester) polymers containing H-bonding units. Preparation and characterization. Macromol Chem Phys 2004, 205:1299-1308.
39. Rodriguez-Lorenzo L., Fytianos K., Blank F., von Garnier C., Rothen-Rutishauser B., Petri-Fink A. Fluorescence-encoded gold nanoparticles: library design and modulation of cellular uptake into dendritic cells. Small 2014, 10(7):1341-1350.
40. Huhn D., Kantner K., Geidel C., Brandholt S., De Cock I., Soenen S.J.H., et al. Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge. ACS Nano 2013, 7(4):3253-3263.
41. Wittmar M., Ellis J.S., Morell F., Unger F., Schumacher J.C., Roberts C.J., et al. Biophysical and transfection studies of an amine-modified poly(vinyl alcohol) for gene delivery. Bioconjug Chem 2005, 16:1390-1398.
42. Nguyen J., Reul R., Roesler S., Dayyoub E., Schmehl T., Gessler T., et al. Amine-modified poly(vinyl alcohol)s as non-viral vectors for siRNA delivery: effects of the degree of amine substitution on physicochemical properties and knockdown efficiency. Pharm Res 2010, 27:2670-2682.
43. Niikura K., Matsunaga T., Suzuki T., Kobayashi S., Yamaguchi H., Orba Y., et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. ACS Nano 2013, 7(5):3926-3938.
44. Piazza M., Collombo M., Zanoni I., Granucci F., Tortora P., Weiss J., et al. Uniform LPS loaded magnetic nanoparticles for the investigation of LPS/TLR4 signalling. Angew Chem Int Ed Engl 2011, 50(3):622-626.
45. Wu H.Y., Chung M.C., Wang C.C., Huang C.H., Liang H.J., Jan T.R. Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells. Part Fibre Toxicol 2013, 10(46).
46. Sumbayev V.V., Yasinska I.M., Garcia C.P., Gilliland D., Lall G.S., Gibbs B.F., et al. Gold nanoparticles downregulate interleukin-1-β-induced pro-inflammatory responses. Small Nano Micro 2012, 1-6.
47. Lechmann M., Berchtold S., Hauber J., Steinkasserer A. CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol 2002, 23(6).
48. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000, 18:767-811.
49. Fujimoto Y., Tedder T.F. CD83: a regulatory molecule of the immune system with great potential for therapeutic application. J Med Dent Sci 2006, 53:85-91.
50. Prechtel A.T., Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells. Arch Dermatol Res 2007, 299(2):59-69.